All Pharma News
price-trendAsk Us
Data Monitoring Committee Recommends Continuing the Trial Evaluating Temelimab

Data Monitoring Committee Recommends Continuing the Trial Evaluating Temelimab
BUSINESSWIRE
11 Dec 2023
Share Share
GeNeuro and Verily Collaborate to Advance Long-COVID Research

GeNeuro and Verily Collaborate to Advance Long-COVID Research
BUSINESSWIRE
19 Oct 2023
Share Share
GeNeuro Announces Recruitment of Patient in Centers in Trial Assessing Temelimab

GeNeuro Announces Recruitment of Patient in Centers in Trial Assessing Temelimab
BUSINESSWIRE
16 Nov 2022
Share Share
Geneuro Receives CHF 6.7M in Funding to Develop Temelimab Against Long-COVID

Geneuro Receives CHF 6.7M in Funding to Develop Temelimab Against Long-COVID
BUSINESSWIRE
13 Dec 2021
Share Share
GeNeuro announces agreement to assess W-ENV and long-Covid syndromes

GeNeuro announces agreement to assess W-ENV and long-Covid syndromes
PHARMACEUTICAL-TECHNOLOGY
27 Sep 2021
Share Share
GeNeuro and Northwestern University Collaborate on HERV-W ENV in Long-haul COVID

GeNeuro and Northwestern University Collaborate on HERV-W ENV in Long-haul COVID
BUSINESSWIRE
24 Sep 2021
Share Share
How GeNeuro`s experimental MS drug might help treat COVID-19

How GeNeuro`s experimental MS drug might help treat COVID-19
Angus Liu FIERCEBIOTECH
15 Apr 2021
Share Share